TODO: OHIE and Gherkin?

Hi all – I’m very sorry, but I have a conflict and won’t be able to attend today’s Architecture call.

Please find, attached, the concept note that I committed to develop.

I will track the meeting minutes to see what has been the result of discussion of this note.

Thanks and warmest regards,



18-09-28 HipTest Concept Note.docx (41.2 KB)


Derek Ritz, P.Eng, CPHIMS-CA

ecGroup Inc.

+1 (905) 515-0045

This communication is intended only for the party to whom it is addressed, and may contain information which is privileged or confidential. Any other delivery, distribution, copying or disclosure is strictly prohibited and is not a waiver of privilege or confidentiality.

From: Thomas, Jamie
Sent: September 26, 2018 10:05 AM
To: Derek Ritz
Cc: Cox, Michelle Louise
Subject: TODO: OHIE and Gherkin?

Hi Derek,

Sent you a message on Skype but just wanted to remind you on the last arch call you mentioned laying out a concept note on how to move Gherkin forward. Didn’t want to lose this activity.

**Jamie Thomas **|****Health Information Project Manager/Communications

Center for Biomedical Informatics

1101 West Tenth Street

Indianapolis, IN 46202

Tel 317-274-9218 | Fax 317-274-9305

Email: | Skype: jamie.thomas5670 | Twitter: @Regenstrief

Confidentiality Notice: The contents of this message and any files transmitted with it may contain confidential and/or privileged information and are intended solely for the use of the named addressee(s). Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state laws. Federal regulations and State laws prohibit you from making further disclosure of such information without the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization for the release of medical or other information is not sufficient for this purpose.

If you have received this message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use of this information by anyone other than the intended recipient is strictly prohibited.